FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

39300811000001103: Avatrombopag 20mg tablets 30 tablet (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 14-Apr 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1124101000001112 Avatrombopag 20mg tablets 30 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1124121000001117 Avatrombopag 20mg tablets 30 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Avatrombopag 20mg tablets 30 tablet Has VMP Avatrombopag 20mg tablets true Inferred relationship Existential restriction modifier
Avatrombopag 20mg tablets 30 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Avatrombopag 20mg tablets 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Avatrombopag false Inferred relationship Existential restriction modifier
Avatrombopag 20mg tablets 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Avatrombopag 20mg tablets 30 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Avatrombopag 20mg tablets 30 tablet Has specific active ingredient Avatrombopag maleate false Inferred relationship Existential restriction modifier
Avatrombopag 20mg tablets 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Avatrombopag 20mg tablets 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Avatrombopag 20mg tablets 30 tablet Has specific active ingredient Avatrombopag maleate true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Doptelet 20mg tablets (Swedish Orphan Biovitrum Ltd) 30 tablet 2 x 15 tablets Is a True Avatrombopag 20mg tablets 30 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start